OTCMKTS:SCIE

SpectraScience (SCIE) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About SpectraScience

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

SCIE Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Financial Twitter, Beware. The Cops Are On to You
See More Headlines
Receive SCIE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SpectraScience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:SCIE
CUSIP
84760E301
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Outstanding Shares
4,968,380,000
Free Float
4,943,542,000
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Michael P. Oliver (Age 76)
    CEO, President, COO & Director
    Comp: $325k
  • Mr. Lowell W. Giffhorn (Age 77)
    CFO & Secretary
    Comp: $90k

SCIE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of SpectraScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SpectraScience investors own include Spectrum Brands (SPB), Bloom Energy (BE), Journey Medical (DERM), CytoDyn (CYDY), Trimble (TRMB), Delek US (DK), Concho Resources (CXO), Cardtronics (CATM), Andersons (ANDE).

How do I buy shares of SpectraScience?

Shares of SCIE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SCIE) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners